Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

Cian M. McCrudden, John W. McBride, Joanne McCaffrey, Emma M. McErlean, Nicholas J. Dunne, Vicky L. Kett, Jonathan A. Coulter, Tracy Robson, Helen O. McCarthy

ABSTRACT

Background: Recent approvals of gene therapies by the FDA and the EMA for treatment of inherited disorders have further opened the door for assessment of nucleic acid pharmaceuticals for clinical usage. Arising from the presence of damaged or inappropriate DNA, cancer is a condition particularly suitable for genetic intervention. The RALA peptide has been shown to be a potent non-viral delivery platform for nucleic acids. This study examines the use of RALA to deliver a plasmid encoding inducible nitric oxide synthase (iNOS) as an anti-cancer treatment. Methods: The physiochemical properties of the RALA/DNA nanoparticles were characterized via dynamic light scattering and transmission electron microscopy. The nanoparticles were labelled with fluorophores and tracked over time using confocal microscopy with orthogonal sections to determine cellular location. In vitro studies were employed to determine functionality of the nanoparticles both for pEGFP-N1 and CMV-iNOS. Nanoparticles were injected intravenously into C57/BL6 mice with blood and serum samples analysed for immune response. PC3-luc2M cells were injected into the left ventricle of SCID mice followed by treatment with RALA/CMV-iNOS nanoparticles to evaluate the tumour response in a metastatic model of prostate cancer. Results: Functional cationic nanoparticles were produced with gene expression in PC-3 prostate cancer cells. Furthermore, repeated administrations of RALA/DNA nanoparticles into immunocompetent mice did not produce any immunological response: neutralization of the vector or release of inflammatory mediators. RALA/CMV-iNOS reduced the clonogenicity of PC-3 cells in vitro, and in an in vivo model of prostate cancer metastasis, systemically delivered RALA/CMV-iNOS significantly improved the survival of mice. Conclusion: These studies further validate RALA as a genetic cargo delivery vehicle and iNOS as a potent therapy for the treatment of cancer. More... »

PAGES

5

References to SciGraph publications

  • 2011-06. Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/s12645-018-0040-x

    DOI

    http://dx.doi.org/10.1186/s12645-018-0040-x

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1104319669

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/29899810


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Queen's University Belfast", 
              "id": "https://www.grid.ac/institutes/grid.4777.3", 
              "name": [
                "School of Pharmacy, Queen\u2019s University Belfast, 97 Lisburn Road, BT9 7BL, Belfast, Northern Ireland, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "McCrudden", 
            "givenName": "Cian M.", 
            "id": "sg:person.0712205067.21", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712205067.21"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Queen's University Belfast", 
              "id": "https://www.grid.ac/institutes/grid.4777.3", 
              "name": [
                "School of Pharmacy, Queen\u2019s University Belfast, 97 Lisburn Road, BT9 7BL, Belfast, Northern Ireland, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "McBride", 
            "givenName": "John W.", 
            "id": "sg:person.0753012067.99", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753012067.99"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Queen's University Belfast", 
              "id": "https://www.grid.ac/institutes/grid.4777.3", 
              "name": [
                "School of Pharmacy, Queen\u2019s University Belfast, 97 Lisburn Road, BT9 7BL, Belfast, Northern Ireland, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "McCaffrey", 
            "givenName": "Joanne", 
            "id": "sg:person.01245611655.20", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245611655.20"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Queen's University Belfast", 
              "id": "https://www.grid.ac/institutes/grid.4777.3", 
              "name": [
                "School of Pharmacy, Queen\u2019s University Belfast, 97 Lisburn Road, BT9 7BL, Belfast, Northern Ireland, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "McErlean", 
            "givenName": "Emma M.", 
            "id": "sg:person.01047572465.85", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047572465.85"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Dublin City University", 
              "id": "https://www.grid.ac/institutes/grid.15596.3e", 
              "name": [
                "School of Mechanical and Manufacturing Engineering, Dublin City University, Dublin, Ireland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Dunne", 
            "givenName": "Nicholas J.", 
            "id": "sg:person.0576201677.45", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576201677.45"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Queen's University Belfast", 
              "id": "https://www.grid.ac/institutes/grid.4777.3", 
              "name": [
                "School of Pharmacy, Queen\u2019s University Belfast, 97 Lisburn Road, BT9 7BL, Belfast, Northern Ireland, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kett", 
            "givenName": "Vicky L.", 
            "id": "sg:person.0636434155.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636434155.14"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Queen's University Belfast", 
              "id": "https://www.grid.ac/institutes/grid.4777.3", 
              "name": [
                "School of Pharmacy, Queen\u2019s University Belfast, 97 Lisburn Road, BT9 7BL, Belfast, Northern Ireland, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Coulter", 
            "givenName": "Jonathan A.", 
            "id": "sg:person.01176723103.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176723103.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Royal College of Surgeons in Ireland", 
              "id": "https://www.grid.ac/institutes/grid.4912.e", 
              "name": [
                "Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, 123 St Stephen\u2019s Green, Dublin 2, Ireland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Robson", 
            "givenName": "Tracy", 
            "id": "sg:person.0755306436.91", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755306436.91"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Queen's University Belfast", 
              "id": "https://www.grid.ac/institutes/grid.4777.3", 
              "name": [
                "School of Pharmacy, Queen\u2019s University Belfast, 97 Lisburn Road, BT9 7BL, Belfast, Northern Ireland, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "McCarthy", 
            "givenName": "Helen O.", 
            "id": "sg:person.0641060036.44", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641060036.44"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1002/(sici)1097-0142(19980515)82:10<1897::aid-cncr12>3.0.co;2-o", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003475415"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/carcin/bgp028", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004570195"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/1541-7786.mcr-15-0057-t", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006964489"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/cmdc.200800257", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007663862"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.jconrel.2014.06.048", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011632537"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2217/nnm.15.115", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012725808"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1038/mt.2016.85", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017600407"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.bmcl.2013.08.066", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018572304"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/jgm.1495", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018577667"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/jgm.1495", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018577667"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1371/journal.pone.0012107", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018935704"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1042/bsr20120120", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020886672"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.omtn.2016.12.010", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022491394"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.jconrel.2016.02.023", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025849329"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1046/j.1464-410x.2001.02231.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034205239"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/0008-5472.can-11-2303", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036455865"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.urology.2009.03.004", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040157505"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.niox.2013.10.003", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041513576"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ijpharm.2016.01.039", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043209283"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00280-011-1654-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048110145", 
              "https://doi.org/10.1007/s00280-011-1654-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1021/acs.molpharmaceut.5b00670", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1055120149"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1517/14712598.2016.1134480", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1067589220"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.3791/2775", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1071422794"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1074955206", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1077800379", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1077892265", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1077910763", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.jconrel.2017.03.390", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1084086345"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/adhm.201601412", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1085050762"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.3390/nano7060120", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1085595364"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1021/acs.nanolett.7b01571", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1086132372"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1021/acsami.7b11024", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1091934963"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2018-12", 
        "datePublishedReg": "2018-12-01", 
        "description": "Background: Recent approvals of gene therapies by the FDA and the EMA for treatment of inherited disorders have further opened the door for assessment of nucleic acid pharmaceuticals for clinical usage. Arising from the presence of damaged or inappropriate DNA, cancer is a condition particularly suitable for genetic intervention. The RALA peptide has been shown to be a potent non-viral delivery platform for nucleic acids. This study examines the use of RALA to deliver a plasmid encoding inducible nitric oxide synthase (iNOS) as an anti-cancer treatment.\nMethods: The physiochemical properties of the RALA/DNA nanoparticles were characterized via dynamic light scattering and transmission electron microscopy. The nanoparticles were labelled with fluorophores and tracked over time using confocal microscopy with orthogonal sections to determine cellular location. In vitro studies were employed to determine functionality of the nanoparticles both for pEGFP-N1 and CMV-iNOS. Nanoparticles were injected intravenously into C57/BL6 mice with blood and serum samples analysed for immune response. PC3-luc2M cells were injected into the left ventricle of SCID mice followed by treatment with RALA/CMV-iNOS nanoparticles to evaluate the tumour response in a metastatic model of prostate cancer.\nResults: Functional cationic nanoparticles were produced with gene expression in PC-3 prostate cancer cells. Furthermore, repeated administrations of RALA/DNA nanoparticles into immunocompetent mice did not produce any immunological response: neutralization of the vector or release of inflammatory mediators. RALA/CMV-iNOS reduced the clonogenicity of PC-3 cells in vitro, and in an in vivo model of prostate cancer metastasis, systemically delivered RALA/CMV-iNOS significantly improved the survival of mice.\nConclusion: These studies further validate RALA as a genetic cargo delivery vehicle and iNOS as a potent therapy for the treatment of cancer.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1186/s12645-018-0040-x", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.5140164", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.5143390", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1042272", 
            "issn": [
              "1868-6958", 
              "1868-6966"
            ], 
            "name": "Cancer Nanotechnology", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "9"
          }
        ], 
        "name": "Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer", 
        "pagination": "5", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "887ed2dc4064efb21cc88d58b3578f8671eedadfdafa312812c085cff732c972"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "29899810"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "101516978"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/s12645-018-0040-x"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1104319669"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/s12645-018-0040-x", 
          "https://app.dimensions.ai/details/publication/pub.1104319669"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T10:36", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000349_0000000349/records_113670_00000004.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://link.springer.com/10.1186%2Fs12645-018-0040-x"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12645-018-0040-x'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12645-018-0040-x'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12645-018-0040-x'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12645-018-0040-x'


     

    This table displays all metadata directly associated to this object as RDF triples.

    225 TRIPLES      21 PREDICATES      60 URIs      21 LITERALS      9 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/s12645-018-0040-x schema:about anzsrc-for:11
    2 anzsrc-for:1112
    3 schema:author N88c6b616b87c4dc0b96a96c46d47704e
    4 schema:citation sg:pub.10.1007/s00280-011-1654-4
    5 https://app.dimensions.ai/details/publication/pub.1074955206
    6 https://app.dimensions.ai/details/publication/pub.1077800379
    7 https://app.dimensions.ai/details/publication/pub.1077892265
    8 https://app.dimensions.ai/details/publication/pub.1077910763
    9 https://doi.org/10.1002/(sici)1097-0142(19980515)82:10<1897::aid-cncr12>3.0.co;2-o
    10 https://doi.org/10.1002/adhm.201601412
    11 https://doi.org/10.1002/cmdc.200800257
    12 https://doi.org/10.1002/jgm.1495
    13 https://doi.org/10.1016/j.bmcl.2013.08.066
    14 https://doi.org/10.1016/j.ijpharm.2016.01.039
    15 https://doi.org/10.1016/j.jconrel.2014.06.048
    16 https://doi.org/10.1016/j.jconrel.2016.02.023
    17 https://doi.org/10.1016/j.jconrel.2017.03.390
    18 https://doi.org/10.1016/j.niox.2013.10.003
    19 https://doi.org/10.1016/j.omtn.2016.12.010
    20 https://doi.org/10.1016/j.urology.2009.03.004
    21 https://doi.org/10.1021/acs.molpharmaceut.5b00670
    22 https://doi.org/10.1021/acs.nanolett.7b01571
    23 https://doi.org/10.1021/acsami.7b11024
    24 https://doi.org/10.1038/mt.2016.85
    25 https://doi.org/10.1042/bsr20120120
    26 https://doi.org/10.1046/j.1464-410x.2001.02231.x
    27 https://doi.org/10.1093/carcin/bgp028
    28 https://doi.org/10.1158/0008-5472.can-11-2303
    29 https://doi.org/10.1158/1541-7786.mcr-15-0057-t
    30 https://doi.org/10.1371/journal.pone.0012107
    31 https://doi.org/10.1517/14712598.2016.1134480
    32 https://doi.org/10.2217/nnm.15.115
    33 https://doi.org/10.3390/nano7060120
    34 https://doi.org/10.3791/2775
    35 schema:datePublished 2018-12
    36 schema:datePublishedReg 2018-12-01
    37 schema:description Background: Recent approvals of gene therapies by the FDA and the EMA for treatment of inherited disorders have further opened the door for assessment of nucleic acid pharmaceuticals for clinical usage. Arising from the presence of damaged or inappropriate DNA, cancer is a condition particularly suitable for genetic intervention. The RALA peptide has been shown to be a potent non-viral delivery platform for nucleic acids. This study examines the use of RALA to deliver a plasmid encoding inducible nitric oxide synthase (iNOS) as an anti-cancer treatment. Methods: The physiochemical properties of the RALA/DNA nanoparticles were characterized via dynamic light scattering and transmission electron microscopy. The nanoparticles were labelled with fluorophores and tracked over time using confocal microscopy with orthogonal sections to determine cellular location. In vitro studies were employed to determine functionality of the nanoparticles both for pEGFP-N1 and CMV-iNOS. Nanoparticles were injected intravenously into C57/BL6 mice with blood and serum samples analysed for immune response. PC3-luc2M cells were injected into the left ventricle of SCID mice followed by treatment with RALA/CMV-iNOS nanoparticles to evaluate the tumour response in a metastatic model of prostate cancer. Results: Functional cationic nanoparticles were produced with gene expression in PC-3 prostate cancer cells. Furthermore, repeated administrations of RALA/DNA nanoparticles into immunocompetent mice did not produce any immunological response: neutralization of the vector or release of inflammatory mediators. RALA/CMV-iNOS reduced the clonogenicity of PC-3 cells in vitro, and in an in vivo model of prostate cancer metastasis, systemically delivered RALA/CMV-iNOS significantly improved the survival of mice. Conclusion: These studies further validate RALA as a genetic cargo delivery vehicle and iNOS as a potent therapy for the treatment of cancer.
    38 schema:genre research_article
    39 schema:inLanguage en
    40 schema:isAccessibleForFree true
    41 schema:isPartOf Na18044b0a4db426f99df79307589fef6
    42 Nd8cd9b4f24b64e8a996e98d16320a539
    43 sg:journal.1042272
    44 schema:name Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer
    45 schema:pagination 5
    46 schema:productId N2c61051a95f3415e875295c0db5bc933
    47 N7c233b3e02e74ebe93637b4547e13bb6
    48 Ne12d28847ab84a4ab8769133165ad045
    49 Nec8443e50a104037a0995671249602fa
    50 Nf05176b2d09e4340aab15620d129d9f7
    51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104319669
    52 https://doi.org/10.1186/s12645-018-0040-x
    53 schema:sdDatePublished 2019-04-11T10:36
    54 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    55 schema:sdPublisher N815d1e33ff794ebfb38e1fa0704142fa
    56 schema:url https://link.springer.com/10.1186%2Fs12645-018-0040-x
    57 sgo:license sg:explorer/license/
    58 sgo:sdDataset articles
    59 rdf:type schema:ScholarlyArticle
    60 N189602030f9d4d2c88abf8821252dced rdf:first sg:person.01176723103.49
    61 rdf:rest N72e6e14e0d2d4f38bcb939c615a36f87
    62 N2540a34350a34e8cb8ad9447b7fbb26b rdf:first sg:person.0641060036.44
    63 rdf:rest rdf:nil
    64 N2c61051a95f3415e875295c0db5bc933 schema:name dimensions_id
    65 schema:value pub.1104319669
    66 rdf:type schema:PropertyValue
    67 N3da870b3267b47b5a7409a8fbad87af2 rdf:first sg:person.01047572465.85
    68 rdf:rest Nfe34e25b2c244b63b3068f0f53455121
    69 N72e6e14e0d2d4f38bcb939c615a36f87 rdf:first sg:person.0755306436.91
    70 rdf:rest N2540a34350a34e8cb8ad9447b7fbb26b
    71 N7c233b3e02e74ebe93637b4547e13bb6 schema:name readcube_id
    72 schema:value 887ed2dc4064efb21cc88d58b3578f8671eedadfdafa312812c085cff732c972
    73 rdf:type schema:PropertyValue
    74 N815d1e33ff794ebfb38e1fa0704142fa schema:name Springer Nature - SN SciGraph project
    75 rdf:type schema:Organization
    76 N88c6b616b87c4dc0b96a96c46d47704e rdf:first sg:person.0712205067.21
    77 rdf:rest Nebeb414188594e2b9e4a0f9d50b8b980
    78 Na18044b0a4db426f99df79307589fef6 schema:issueNumber 1
    79 rdf:type schema:PublicationIssue
    80 Nd8cd9b4f24b64e8a996e98d16320a539 schema:volumeNumber 9
    81 rdf:type schema:PublicationVolume
    82 Nd92cac8713434afbbacc7c16db6c2222 rdf:first sg:person.01245611655.20
    83 rdf:rest N3da870b3267b47b5a7409a8fbad87af2
    84 Ne12d28847ab84a4ab8769133165ad045 schema:name pubmed_id
    85 schema:value 29899810
    86 rdf:type schema:PropertyValue
    87 Nebeb414188594e2b9e4a0f9d50b8b980 rdf:first sg:person.0753012067.99
    88 rdf:rest Nd92cac8713434afbbacc7c16db6c2222
    89 Nec8443e50a104037a0995671249602fa schema:name doi
    90 schema:value 10.1186/s12645-018-0040-x
    91 rdf:type schema:PropertyValue
    92 Nf05176b2d09e4340aab15620d129d9f7 schema:name nlm_unique_id
    93 schema:value 101516978
    94 rdf:type schema:PropertyValue
    95 Nf9d352f7c213429897630dc71978f404 rdf:first sg:person.0636434155.14
    96 rdf:rest N189602030f9d4d2c88abf8821252dced
    97 Nfe34e25b2c244b63b3068f0f53455121 rdf:first sg:person.0576201677.45
    98 rdf:rest Nf9d352f7c213429897630dc71978f404
    99 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    100 schema:name Medical and Health Sciences
    101 rdf:type schema:DefinedTerm
    102 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    103 schema:name Oncology and Carcinogenesis
    104 rdf:type schema:DefinedTerm
    105 sg:grant.5140164 http://pending.schema.org/fundedItem sg:pub.10.1186/s12645-018-0040-x
    106 rdf:type schema:MonetaryGrant
    107 sg:grant.5143390 http://pending.schema.org/fundedItem sg:pub.10.1186/s12645-018-0040-x
    108 rdf:type schema:MonetaryGrant
    109 sg:journal.1042272 schema:issn 1868-6958
    110 1868-6966
    111 schema:name Cancer Nanotechnology
    112 rdf:type schema:Periodical
    113 sg:person.01047572465.85 schema:affiliation https://www.grid.ac/institutes/grid.4777.3
    114 schema:familyName McErlean
    115 schema:givenName Emma M.
    116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047572465.85
    117 rdf:type schema:Person
    118 sg:person.01176723103.49 schema:affiliation https://www.grid.ac/institutes/grid.4777.3
    119 schema:familyName Coulter
    120 schema:givenName Jonathan A.
    121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176723103.49
    122 rdf:type schema:Person
    123 sg:person.01245611655.20 schema:affiliation https://www.grid.ac/institutes/grid.4777.3
    124 schema:familyName McCaffrey
    125 schema:givenName Joanne
    126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245611655.20
    127 rdf:type schema:Person
    128 sg:person.0576201677.45 schema:affiliation https://www.grid.ac/institutes/grid.15596.3e
    129 schema:familyName Dunne
    130 schema:givenName Nicholas J.
    131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576201677.45
    132 rdf:type schema:Person
    133 sg:person.0636434155.14 schema:affiliation https://www.grid.ac/institutes/grid.4777.3
    134 schema:familyName Kett
    135 schema:givenName Vicky L.
    136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636434155.14
    137 rdf:type schema:Person
    138 sg:person.0641060036.44 schema:affiliation https://www.grid.ac/institutes/grid.4777.3
    139 schema:familyName McCarthy
    140 schema:givenName Helen O.
    141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641060036.44
    142 rdf:type schema:Person
    143 sg:person.0712205067.21 schema:affiliation https://www.grid.ac/institutes/grid.4777.3
    144 schema:familyName McCrudden
    145 schema:givenName Cian M.
    146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712205067.21
    147 rdf:type schema:Person
    148 sg:person.0753012067.99 schema:affiliation https://www.grid.ac/institutes/grid.4777.3
    149 schema:familyName McBride
    150 schema:givenName John W.
    151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753012067.99
    152 rdf:type schema:Person
    153 sg:person.0755306436.91 schema:affiliation https://www.grid.ac/institutes/grid.4912.e
    154 schema:familyName Robson
    155 schema:givenName Tracy
    156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755306436.91
    157 rdf:type schema:Person
    158 sg:pub.10.1007/s00280-011-1654-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048110145
    159 https://doi.org/10.1007/s00280-011-1654-4
    160 rdf:type schema:CreativeWork
    161 https://app.dimensions.ai/details/publication/pub.1074955206 schema:CreativeWork
    162 https://app.dimensions.ai/details/publication/pub.1077800379 schema:CreativeWork
    163 https://app.dimensions.ai/details/publication/pub.1077892265 schema:CreativeWork
    164 https://app.dimensions.ai/details/publication/pub.1077910763 schema:CreativeWork
    165 https://doi.org/10.1002/(sici)1097-0142(19980515)82:10<1897::aid-cncr12>3.0.co;2-o schema:sameAs https://app.dimensions.ai/details/publication/pub.1003475415
    166 rdf:type schema:CreativeWork
    167 https://doi.org/10.1002/adhm.201601412 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085050762
    168 rdf:type schema:CreativeWork
    169 https://doi.org/10.1002/cmdc.200800257 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007663862
    170 rdf:type schema:CreativeWork
    171 https://doi.org/10.1002/jgm.1495 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018577667
    172 rdf:type schema:CreativeWork
    173 https://doi.org/10.1016/j.bmcl.2013.08.066 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018572304
    174 rdf:type schema:CreativeWork
    175 https://doi.org/10.1016/j.ijpharm.2016.01.039 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043209283
    176 rdf:type schema:CreativeWork
    177 https://doi.org/10.1016/j.jconrel.2014.06.048 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011632537
    178 rdf:type schema:CreativeWork
    179 https://doi.org/10.1016/j.jconrel.2016.02.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025849329
    180 rdf:type schema:CreativeWork
    181 https://doi.org/10.1016/j.jconrel.2017.03.390 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084086345
    182 rdf:type schema:CreativeWork
    183 https://doi.org/10.1016/j.niox.2013.10.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041513576
    184 rdf:type schema:CreativeWork
    185 https://doi.org/10.1016/j.omtn.2016.12.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022491394
    186 rdf:type schema:CreativeWork
    187 https://doi.org/10.1016/j.urology.2009.03.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040157505
    188 rdf:type schema:CreativeWork
    189 https://doi.org/10.1021/acs.molpharmaceut.5b00670 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055120149
    190 rdf:type schema:CreativeWork
    191 https://doi.org/10.1021/acs.nanolett.7b01571 schema:sameAs https://app.dimensions.ai/details/publication/pub.1086132372
    192 rdf:type schema:CreativeWork
    193 https://doi.org/10.1021/acsami.7b11024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091934963
    194 rdf:type schema:CreativeWork
    195 https://doi.org/10.1038/mt.2016.85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017600407
    196 rdf:type schema:CreativeWork
    197 https://doi.org/10.1042/bsr20120120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020886672
    198 rdf:type schema:CreativeWork
    199 https://doi.org/10.1046/j.1464-410x.2001.02231.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1034205239
    200 rdf:type schema:CreativeWork
    201 https://doi.org/10.1093/carcin/bgp028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004570195
    202 rdf:type schema:CreativeWork
    203 https://doi.org/10.1158/0008-5472.can-11-2303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036455865
    204 rdf:type schema:CreativeWork
    205 https://doi.org/10.1158/1541-7786.mcr-15-0057-t schema:sameAs https://app.dimensions.ai/details/publication/pub.1006964489
    206 rdf:type schema:CreativeWork
    207 https://doi.org/10.1371/journal.pone.0012107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018935704
    208 rdf:type schema:CreativeWork
    209 https://doi.org/10.1517/14712598.2016.1134480 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067589220
    210 rdf:type schema:CreativeWork
    211 https://doi.org/10.2217/nnm.15.115 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012725808
    212 rdf:type schema:CreativeWork
    213 https://doi.org/10.3390/nano7060120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085595364
    214 rdf:type schema:CreativeWork
    215 https://doi.org/10.3791/2775 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071422794
    216 rdf:type schema:CreativeWork
    217 https://www.grid.ac/institutes/grid.15596.3e schema:alternateName Dublin City University
    218 schema:name School of Mechanical and Manufacturing Engineering, Dublin City University, Dublin, Ireland
    219 rdf:type schema:Organization
    220 https://www.grid.ac/institutes/grid.4777.3 schema:alternateName Queen's University Belfast
    221 schema:name School of Pharmacy, Queen’s University Belfast, 97 Lisburn Road, BT9 7BL, Belfast, Northern Ireland, UK
    222 rdf:type schema:Organization
    223 https://www.grid.ac/institutes/grid.4912.e schema:alternateName Royal College of Surgeons in Ireland
    224 schema:name Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, 123 St Stephen’s Green, Dublin 2, Ireland
    225 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...